Close Menu

NEW YORK (GenomeWeb) – Biocept reported after the close of the market on Thursday that its first quarter revenues rose dramatically year over year, influenced by a conversion to accrual-based revenue.

For the three months ended March 31, the liquid biopsy firm's total revenues rose to $1.7 million from $221,369 the prior-year quarter. Within Biocept's overall revenue, $897,000 came from commercial testing and another $61,000 was from the firm's development services.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

23andMe has a holiday popup shop at a mall and could open additional stores, Bloomberg reports.

By studying koalas and a retrovirus that infects them, researchers may have uncovered a new sort of 'immune response' that occurs at the genomic level, Agence France Presse reports.

NPR reports that the first person in the US given a gene editing-based therapy for a genetic disorder is heading home.

In Science this week: ancient genomes reveal social inequality within individual households, new method for quantifying genetic variation in gene dosage, and more.